AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
11 Jun, 2026, 11.48 AM IST
Hetero partners with Richter to develop, market Semaglutide injection globallyHyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...
10 Jun, 2026, 06.16 PM IST
Worried about future of your child with special needs? How making a trust can help your child when you are not aroundFor parents of children with special needs, a special needs trust offers a vital long-term plan for their child's care and financial securi...
10 Jun, 2026, 03.52 PM IST
Paediatric healthcare startup Hoola Health raises $5 million from Peak XV’s Surge, othersThe Bengaluru-headquartered startup, founded in 2024 by Deeksha Senguttuvan, offers paediatric consultations, vaccinations, diagnostics, de...
10 Jun, 2026, 02.26 PM IST
$10. 6 billion deal: GSK to buy US cancer specialist NuvalentBritish pharmaceutical giant GSK has announced a massive $10.6 billion deal to acquire Nuvalent. This Boston-based company specializes in c...
10 Jun, 2026, 01.06 AM IST
Quote of the Day by Brooke Shields: 'I've never found therapy to be a sign of...' – Coming-of-age romance adventure The Blue Lagoon star's powerful quote on therapy, strength and self-reflectionActress Brooke Shields shared a powerful thought on therapy. She believes looking at oneself honestly takes courage. Shields' journey shows...
09 Jun, 2026, 11.24 PM IST
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
09 Jun, 2026, 08.48 PM IST
GSK in talks to buy cancer biotech Nuvalent for more than $9 billionBritish drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...
09 Jun, 2026, 11.45 AM IST
West Bengal's electronics factory push; Fed jitters hit TCSWest Bengal is exploring ways to expand electronics manufacturing under EMC 2.0. This and more in today's ETtech Top 5.
08 Jun, 2026, 07.40 PM IST
Kiran Mazumdar-Shaw's Immuneel Therapeutics raises Rs 100 crore from Singularity AMC, Rainmatter, othersThe Bengaluru-based company makes CAR-T therapy, a form of cancer treatment where a patient’s own immune cells are taken out, trained in a ...
08 Jun, 2026, 01.27 PM IST
Q4 FY26 earnings: Metal companies lead growth, backed by robust volumes and favourable pricing trendsET Wealth presents an 8-quarter earnings assessment report of various sectors. The year-on-year net profit growth for 18 sectors is present...
08 Jun, 2026, 11.30 AM IST
In 1987, ophthalmologist Dr. Jean Carruthers noticed her crossed-eye patients' frown lines were vanishing, and Botox accidentally became cosmetic history's biggest hitOriginally developed to address eye disorders such as blepharospasm, Botox has evolved into a key player in the cosmetic industry since its...
06 Jun, 2026, 06.04 PM IST
Sorry Gen Z, but knowing therapy words doesn't make you emotionally intelligentAs therapy-related language becomes increasingly common, many people are questioning whether knowing mental health terminology automaticall...
05 Jun, 2026, 01.04 AM IST
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
03 Jun, 2026, 02.36 PM IST
Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage studyThe study, which followed patients for over five years, found that those who received the regimen were nine times more likely to have lit...
31 May, 2026, 05.38 PM IST
Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
31 May, 2026, 05.00 PM IST
Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
27 May, 2026, 08.27 PM IST